Literature DB >> 25043849

Deregulated FOX genes in Hodgkin lymphoma.

Stefan Nagel1, Corinna Meyer, Maren Kaufmann, Hans G Drexler, Roderick A F MacLeod.   

Abstract

FOX genes encode transcription factors which regulate basic developmental processes during embryogenesis and in the adult. Several FOX genes show deregulated expression in particular malignancies, representing oncogenes or tumor suppressors. Here, we screened six Hodgkin lymphoma (HL) cell lines for FOX gene activity by comparative microarray profiling, revealing overexpression of FOXC1 and FOXD1, and reduced transcription of FOXN3, FOXO1, and FOXP1. In silico expression analyses of these FOX gene candidates in HL patient samples supported the cell line data. Chromosomal analyses demonstrated an amplification of the FOXC1 locus at 6p25 and a gain of the FOXR2 locus at Xp11, indicting genomic aberrations for their upregulation. Comparative expression profiling and ensuing stimulation experiments revealed implementation of the TGFβ- and WNT-signaling pathways in deregulation of FOXD1 and FOXN3. Functional analysis of FOXP1 implicated miR9 and miR34a as upstream regulators and PAX5, TCF3, and RAG2 as downstream targets. A similar exercise for FOXC1 revealed repression of MSX1 and activation of IPO7, both mediating inhibition of the B-cell specific homeobox gene ZHX2. Taken together, our data show that aberrantly expressed FOX genes and their downstream targets are involved in the pathogenesis of HL via deregulation of B-cell differentiation and may represent useful diagnostic markers and/or therapeutic targets.
© 2014 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25043849     DOI: 10.1002/gcc.22204

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  26 in total

1.  Novel tumor-suppressor FOXN3 is downregulated in adult acute myeloid leukemia.

Authors:  Hang He; Jinjing Zhang; Yi Qu; Yue Wang; Yan Zhang; Xiaojing Yan; Yan Li; Rui Zhang
Journal:  Oncol Lett       Date:  2019-05-31       Impact factor: 2.967

Review 2.  The multisystemic functions of FOXD1 in development and disease.

Authors:  Paula Quintero-Ronderos; Paul Laissue
Journal:  J Mol Med (Berl)       Date:  2018-06-29       Impact factor: 4.599

3.  Diagnostic and prognostic value of FOXD1 expression in head and neck squamous cell carcinoma.

Authors:  Shijie Qiu; Dan Li; Zhisen Shen; Qun Li; Yi Shen; Hongxia Deng; Yidong Wu; Chongchang Zhou
Journal:  J Cancer       Date:  2021-01-01       Impact factor: 4.207

4.  The FOXN3-NEAT1-SIN3A repressor complex promotes progression of hormonally responsive breast cancer.

Authors:  Wanjin Li; Zihan Zhang; Xinhua Liu; Xiao Cheng; Yi Zhang; Xiao Han; Yu Zhang; Shumeng Liu; Jianguo Yang; Bosen Xu; Lin He; Luyang Sun; Jing Liang; Yongfeng Shang
Journal:  J Clin Invest       Date:  2017-08-14       Impact factor: 14.808

Review 5.  Zinc fingers and homeoboxes family in human diseases.

Authors:  Y Liu; D Ma; C Ji
Journal:  Cancer Gene Ther       Date:  2015-04-10       Impact factor: 5.987

6.  High expression of FOXR2 in breast cancer correlates with poor prognosis.

Authors:  Haiping Song; Wenshan He; Xiaoqing Huang; Huiqiong Zhang; Tao Huang
Journal:  Tumour Biol       Date:  2015-11-23

7.  Combined Identification of Novel Markers for Diagnosis and Prognostic of Classic Hodgkin Lymphoma.

Authors:  Zhixing Kuang; Jiannan Tu; Xun Li
Journal:  Int J Gen Med       Date:  2021-12-18

Review 8.  A narrative review of the roles of muscle segment homeobox transcription factor family in cancer.

Authors:  Chao Liu; Mengxi Huang; Chao Han; Huiyu Li; Jing Wang; Yadi Huang; Yanyan Chen; Jialong Zhu; Gongbo Fu; Hanqing Yu; Zengjie Lei; Xiaoyuan Chu
Journal:  Ann Transl Med       Date:  2021-05

9.  Aberrantly Expressed OTX Homeobox Genes Deregulate B-Cell Differentiation in Hodgkin Lymphoma.

Authors:  Stefan Nagel; Stefan Ehrentraut; Corinna Meyer; Maren Kaufmann; Hans G Drexler; Roderick A F MacLeod
Journal:  PLoS One       Date:  2015-09-25       Impact factor: 3.240

10.  Transcription factor Zhx2 restricts NK cell maturation and suppresses their antitumor immunity.

Authors:  Siyu Tan; Xiaowei Guo; Mengzhen Li; Tixiao Wang; Zehua Wang; Chunyang Li; Zhuanchang Wu; Nailin Li; Lifen Gao; Xiaohong Liang; Chunhong Ma
Journal:  J Exp Med       Date:  2021-07-19       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.